Bolt Biotherapeutics, Inc. (BOLT)

SEC filing

Bolt Biotherapeutics, Inc.

BOLT · CIK 1641281

4 · Sep 21, 2026 · Senior VP, Finance and PAO Nemec Sarah bought 509 shares at $3.88/share ($1,973); sold 7,842 shares at $3.32/share ($26,072)

Senior VP, Finance and PAO Nemec Sarah bought 509 shares at $3.88/share ($1,973); sold 7,842 shares at $3.32/share ($26,072)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).